Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Spinal segmental myoclonus as an unusual presentation of multiple sclerosis.
Fingolimod induces the transition to a nerve regeneration promoting Schwann cell phenotype.
IFN-Gamma Inhibits JC Virus Replication in Glial Cells by Suppressing T-Antigen Expression.
Cognitive processing speed has minimal influence on the construct validity of Multiple Sclerosis Walking Scale-12 scores.
Changes in normal appearing spinal cord in multiple sclerosis: another brick in the wall.
Diagnostic data for neurological conditions in interRAI assessments in home care, nursing home and mental health care settings: a validity study.
Cross-sectional area variations of internal jugular veins during supine head rotation in multiple sclerosis patients with chronic cerebrospinal venous insufficiency: a prospective diagnostic controlled study with duplex ultrasound investigation.
The Stress-Buffering Effects of Hope on Adjustment to Multiple Sclerosis.
Multiple sclerosis: Defect in peripheral B-cell tolerance identified in MS.
Specific immune complexes augment in vitro acetylcholine receptor-specific T-cell proliferation.
Proteomic pattern analysis discriminates among multiple sclerosis-related disorders.
Cerebral adrenoleukodystrophy: a demyelinating disease that leaves the door wide open.
Anti-CD20 antibody wows in multiple sclerosis.
Epstein Barr Virus and Mycobacterium avium subsp. paratuberculosis peptides are recognized in sera and cerebrospinal fluid of MS patients.
Constructing an adaptive care model for the management of disease-related symptoms throughout the course of multiple sclerosis--performance improvement CME.
Bilateral optic neuritis associated with scrub typhus.
Smoking worsens multiple sclerosis prognosis: Two different pathways are involved.
Correction: The Nuclear IκB Family Protein IκBNS Influences the Susceptibility to Experimental Autoimmune Encephalomyelitis in a Murine Model.
Whom to Target for Falls-Prevention Trials: Recommendations from the International MS Falls Prevention Research Network.
Responsiveness of selected outcome measures of participation restriction and quality of life in patients with multiple sclerosis.
Natalizumab is effective in controlling the inflammatory rebound after its discontinuation and failure of an alternative treatment.
Peptide motif for the rat MHC class II molecule RT1.Da: similarities to the multiple sclerosis-associated HLA-DRB1*1501 molecule.
Multiple sclerosis: Reprogramming the immune repertoire with alemtuzumab in MS.
Review: Effect study of sex hormone in the multiple sclerosis of common neurological disorders.
Predicting medication adherence in multiple sclerosis using telephone-based home monitoring.
Pages
« first
‹ previous
…
668
669
670
671
672
673
674
675
676
…
next ›
last »